ETrade Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

ETrade Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-19,900	Closed	-$1.19M	–	886
2018 Q4	$1.19M	Sell	19,900 -1,231	-6%	-$73.9K	0.04%	255
2018 Q3	$1.36M	Sell	21,131 -10,689	-34%	-$596K	0.04%	268
2018 Q2	$1.43M	Sell	31,820 -634	-2%	-$25.3K	0.04%	249
2018 Q1	$1.01M	Sell	32,454 -1,556	-5%	-$51.2K	0.03%	346
2017 Q4	$1.02M	Buy	34,010 +1,440	+4%	+$41.7K	0.03%	343
2017 Q3	$1.07M	Buy	32,570 +5,838	+22%	+$202K	0.04%	311
2017 Q2	$894K	Sell	26,732 -1,397	-5%	-$41.7K	0.03%	303
2017 Q1	$815K	Buy	+28,129	New	+$697K	0.03%	321

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ETrade Capital Management's BEAT Position: Q1 2019 in Review

ETrade Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 19,900 shares — an estimated $1.19M sold.

ETrade Capital Management first reported a position in BEAT in Q1 2017 and held it in 8 quarters. The position peaked at $1.43M in Q2 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

ETrade Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
ETrade Capital Management sold 19,900 BioTelemetry, Inc. shares in Q1 2019, an estimated $1.19M.
ETrade Capital Management first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 8 quarters.
ETrade Capital Management's BioTelemetry, Inc. position peaked at $1.43M in Q2 2018.
311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on ETrade Capital Management's 13F filing for Q1 2019, filed 13 May 2019.